L'édition de cet ISBN n'est malheureusement plus disponible.
Afficher les exemplaires de cette édition ISBNISRAEL HANIN, PhD, is Professor and Chair Emeritus in theDepartment of Pharmacology at Loyola University Chicago. Heformerly worked at the National Institute of Mental Health,Laboratory of Preclinical Pharmacology, and at the University ofPittsburgh Department of Psychiatry. Dr. Hanin′s research hasfocused on cholinergic mechanisms, animal models for Alzheimer′sdisease, and the potential role of glycosaminoglycans in thetreatment of Alzheimer′s disease.
MICHAEL KUHAR, PhD, is currently a Candler Professor andGeorgia Research Alliance Professor of Neuropharmacology at theYerkes Primate Center at Emory University. He previously was aprofessor in the Neuroscience Department at Johns Hopkins, and abranch chief at the National Institute on Drug Abuse. Dr. Kuhar haspublished more than 800 articles, abstracts, book chapters,reviews, and patents.
PHIL SKOLNICK, PhD, D.Sc. (hon.), is Executive VicePresident and Chief Scientific Officer for DOV Pharmaceutical, Inc.He was formerly a Lilly Fellow in Neuroscience and also served asChief of the Laboratory of Neuroscience, National Institutes ofHealth.
Recognizing the central role of neuropharmacology in drugdevelopment, therapy, and the potential for developing novelclasses of neuropharmacologic agents stemming from currentresearch, prominent experts collaborated to develop thiscomprehensive, up–to–date reference that consolidates informationabout the latest approaches and advances in neuropharmacology ingeneral, and in the research and treatment of specific conditions.Edited by leaders in neuropharmacology and featuring chapters byrespected authorities in their specialty areas, Handbook ofContemporary Neuropharmacology is an invaluable resource forpharmacologists, neurologists, psychiatrists, pharmaceuticalprofessionals, and students. It covers basic neuropharmacology andthen delves into its applications in research and in treatingspecific disorders:
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Frais de port :
EUR 48,99
De Allemagne vers Etats-Unis
Description du livre Etat : New. DAVID R. SIBLEY, PhD, is a Senior Investigator and Chief of the Molecular Neuropharmacology Section in the National Institute of Neurological Disorders and Stroke, National Institutes of Health. His laboratory is currently investigating the molecular, cellu. N° de réf. du vendeur 556561915
Description du livre Etat : New. New. In shrink wrap. Looks like an interesting title! 4.05. N° de réf. du vendeur Q-0471660531